155 related articles for article (PubMed ID: 37635422)
21. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
[TBL] [Abstract][Full Text] [Related]
23. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
Abe H; Kamimura K; Okuda S; Watanabe Y; Inoue J; Aoyagi Y; Wakai T; Kominami R; Terai S
Cancer Med; 2023 Jul; 12(14):15650-15663. PubMed ID: 37293953
[TBL] [Abstract][Full Text] [Related]
24. Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
[TBL] [Abstract][Full Text] [Related]
25. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.
Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
[TBL] [Abstract][Full Text] [Related]
26. Role of the transcription factor Bcl11b in development and lymphomagenesis.
Kominami R
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
[TBL] [Abstract][Full Text] [Related]
27. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
28. The epidemiology and prognosis of patients with primary gastric T-cell lymphoma in the SEER program.
Zhang M; Xiao F; Lin M; Chen M; Hou J; Huang H
Cancer Med; 2023 Jan; 12(1):84-98. PubMed ID: 35698430
[TBL] [Abstract][Full Text] [Related]
29. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
Champagne DP; Shockett PE
Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
[TBL] [Abstract][Full Text] [Related]
30. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
Fahey L; Donohoe G; Broin PÓ; Morris DW
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
[TBL] [Abstract][Full Text] [Related]
31. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
[TBL] [Abstract][Full Text] [Related]
32. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
[TBL] [Abstract][Full Text] [Related]
33. Variation in dicer gene is associated with increased survival in T-cell lymphoma.
Li X; Tian X; Zhang B; Zhang Y; Chen J
PLoS One; 2012; 7(12):e51640. PubMed ID: 23251602
[TBL] [Abstract][Full Text] [Related]
34. The role of BCL11B in regulating the proliferation of human naive T cells.
Chen S; Huang X; Chen S; Yang L; Shen Q; Zheng H; Li B; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hum Immunol; 2012 May; 73(5):456-64. PubMed ID: 22426257
[TBL] [Abstract][Full Text] [Related]
35. [A case report of BCL11B mutation induced neurodevelopmental disorder and literature review].
Yan S; Wei YS; Yang QY; Yang L; Zeng T; Tang XM; Zhao XD; An YF
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):223-227. PubMed ID: 32135595
[No Abstract] [Full Text] [Related]
36. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
[TBL] [Abstract][Full Text] [Related]
37. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
[TBL] [Abstract][Full Text] [Related]
38. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
[TBL] [Abstract][Full Text] [Related]
39. Alteration of Bcl11b upon stimulation of both the MAP kinase- and Gsk3-dependent signaling pathways in double-negative thymocytes.
Selman WH; Esfandiari E; Filtz TM
Biochem Cell Biol; 2019 Apr; 97(2):201-213. PubMed ID: 30352171
[TBL] [Abstract][Full Text] [Related]
40. BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.
Yang WJ; Sun YF; Jin AL; Lv LH; Zhu J; Wang BL; Zhou Y; Zhang CY; Wang H; Hu B; Wang PX; Te L; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Cell Death Dis; 2020 Oct; 11(10):895. PubMed ID: 33093445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
